Growth Hormone

AOD-9604

Mechanism

Modified fragment of growth hormone (residues 177-191) developed for fat-loss applications. Mimics the lipolytic action of full-length GH without affecting blood glucose or IGF-1. Approved as a complementary medicine in Australia (TGA).

Typical dose

300mcg subcutaneous once daily

Cycle length

12-16 weeks on, 4 weeks off

Form

Injectable (subcutaneous)

Deep dives on AOD-9604

Best Peptide Protocol for Knee Cartilage Repair and Osteoarthritis Pain (2026)Evidence-based guide to peptide protocol for knee cartilage repair: BPC-157, TB-500, GHK-Cu mechanisms, intra-articular dosing, contraindications, and 2026 regulatory
What the FDA Reclassification Actually Means for Peptide UsersFDA peptide reclassification 2026: what Category 2 to Category 1 actually means for users, what's changed, what hasn't, and what to expect from the July PCAC meeting.
Which Peptides Are Legal Again in 2026? The Full FDA ListComplete guide to the 14 peptides returning to legal compounding status in 2026 after RFK Jr.'s FDA reclassification announcement. Every compound explained.

Get the Pre-Protocol Checklist

Free checklist plus weekly protocols, research breakdowns, and tactical guides. No spam. Unsubscribe anytime.